Fact CheckerSign in

NCT07183072Recruiting

Patients Diagnosed With Scleroderma: Physical Performance and Functionality

Investigating the Relationship Between the Biopsychosocial Status of Individuals Diagnosed With Scleroderma and Their Physical Performance and Functionality

Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. In light of all this literature, the aim was to evaluate the biopsychosocial characteristics of both pediatric and adult scleroderma patients and to examine their physical performance and functionality. Additionally, this study aims to identify effective tests that can be used in future research to assess physical performance and functionality in individuals diagnosed with scleroderma.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
13 Sept 2025
Start date
4 Aug 2025
Primary completion date
Aug 2027
Lead sponsor
Hacettepe University
NCT number
NCT07183072

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 4 Aug 2025 to the primary completion date, Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies

Other

  • Cases that are not willing to participate in the study will be excluded.
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study
    • \*For adults diagnosed with scleroderma\*
  • Individuals who are not willing to participate in the study will be excluded.
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study

Who the study is looking for

  • Cases diagnosed with scleroderma,
  • Cases aged 7-18 years will be included.
  • Individuals diagnosed with scleroderma,
  • Individuals over the age of 18 will be included.

Criteria the registry did not label

  • \*For a child diagnosed with scleroderma\*

Age in the registry: 7 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hacettepe University
Coordinator of this site? Confirm its status
ÇankayaTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.